Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances.

Lu ML; Lin SK; Chang WH

首页> 外文期刊>The journal of clinical psychiatry >Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances.

【24h】

Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances.

机译：辅助氟伏沙明抑制氯氮平相关的体重增加和代谢紊乱。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND: Adjunctive fluvoxamine inhibits clozapine metabolism and decreases plasma norclozapine (a toxic metabolite of clozapine) to clozapine ratios. This study aimed to demonstrate the effects of fluvoxamine on clozapine-related weight gain, hyperglycemia, and lipid abnormalities. METHOD: Sixty-eight treatment-resistant inpatients with a DSM-IV diagnosis of schizophrenia were randomly assigned to 2 treatment groups for 12 weeks. The monotherapy group (N = 34) received clozapine (

机译：背景：氟伏沙明辅助剂可抑制氯氮平的代谢，并降低血浆降氯氮平（氯氮平的有毒代谢产物）与氯氮平的比率。这项研究旨在证明氟伏沙明对氯氮平相关的体重增加，高血糖症和脂质异常的影响。方法：将68名DSM-IV诊断为精神分裂症的对治疗有抵抗力的患者随机分为2个治疗组，共12周。单药治疗组（N = 34）接受氯氮平（

著录项

来源
《The journal of clinical psychiatry》 |2004年第6期|共6页
作者
Lu ML; Lin SK; Chang WH;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
Clozapine; Fluvoxamine; Triglycerides; Plasma; 氯氮平; 氟伏沙明; 甘油三酯类; 血浆;

机译：Clozapine;Fluvoxamine;Triglycerides;Plasma;氯氮平;氟伏沙明;甘油三酯类;血浆;

相似文献

外文文献
中文文献
专利

1. Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances. [J] . Lu ML, Lin SK, Chang WH The journal of clinical psychiatry . 2004,第6期

机译：辅助氟伏沙明抑制氯氮平相关的体重增加和代谢紊乱。
2. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine [J] . Sue Patterson, Dylan Flaws, Savio Sardinha, BMJ Open . 2018,第3期

机译：CoMET：一项新的开始于氯氮平上的精神分裂症患者共同服用甲福明作为辅助治疗以减轻体重增加和代谢综合征的随机对照试验的方案
3. A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics. [J] . Nwosu BU, Meltzer B, Maranda L, Journal of pediatric endocrinology & metabolism: JPEM . 2011,第9a10期

机译：辅助维生素D治疗在控制第二代抗精神病药的体重增加和代谢副作用方面的潜在作用。
4. Sex Differences in the Impact of Sire Exposure to BPA on Weight Gain, Glucose Tolerance, and Metabolic Endpoints in Offspring [C] . S. J. Sumner, T. Fennell, S. McRitchie, Annual conference of the International Society of Exposure Science . 2017

机译：母猪接触BPA对后代体重增加，葡萄糖耐量和代谢终点的影响中的性别差异
5. The Association of Prepregnancy Body Mass Index, Gestational Weight Gain, and Child Birth Weight with Markers of Metabolic Dysfunction in Obese Children and Adolescents [D] . Pearson, Kelsey Ann. 2017

机译：肥胖儿童和青少年的妊娠体重指数，妊娠体重增加和儿童出生体重与代谢功能障碍的相关性
6. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine [O] . Dan Siskind, Nadia Friend, Anthony Russell, 2018

机译：CoMET：一项新的开始于氯氮平上的精神分裂症患者的联合用药二甲双胍联合用药以减轻体重增加和代谢综合征的辅助治疗的随机对照试验方案
7. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine [O] . Dan Siskind, Nadia Friend, Anthony Russell, 2018

机译：COMET：用于在氯氮平新开始的精神分裂症患者衰减体重增加和代谢综合征的辅助治疗的随机对照试验的方案

Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances.

摘要

著录项

相似文献

相关主题

期刊订阅